Patents Assigned to SENOGEN GMBH
  • Patent number: 12779245
    Abstract: Near-infrared/Mid-infrared lasers are used to de-claudicate glaucomatous tissue, translocate extra-ocular muscles, thermally pulsate palpebrae, and permeate/vasodilate superficial/epi-scleral membranes for dmg delivery. Diffractive optic element-mediated laser patterns may irradiate eye tissues under pulsed or continuous wave regimes with programmable durations and sequences for efficient treatments while minimizing adverse effects.
    Type: Grant
    Filed: June 23, 2021
    Date of Patent: November 3, 2026
    Assignee: SENOGEN GMBH
    Inventors: Anjali Herekar, Rajeev Herekar, Satish Herekar
  • Patent number: 12622809
    Abstract: Apparatus, systems, and methods for treating an eye utilizing ab externo pressure wave generation. The shockwave generator comprises a housing comprising a fluid-filled chamber and an eye-contacting surface or chamber configured to contact a surface of the eye. First and second coaxially-aligned electrodes disposed within the housing are configured to generate an electric arc across a gap between the electrode tips when energized and thus produce a shockwave in a fluid of the fluid-filled chamber. The shockwave generator is coupled to the surface of the eye before focusing a shockwave to a pre-determined location on or below the surface of the eye. A plurality of shockwave generators may be disposed within a fluid-filled chamber of a contact lens, which may comprise a contact balloon.
    Type: Grant
    Filed: August 10, 2020
    Date of Patent: May 12, 2026
    Assignee: SENOGEN GMBH
    Inventors: Rajeev Herekar, Anjali Herekar, Satish Herekar